Research Areas:

Internal Medicine, Medical Genetics, Immunology, Medicine and Artificial Intelligence

Personal Profile:

Professional and Technical Grade II; Chief Physician of Nephrology, Professor of Internal Medicine, and Research Fellow of Biomedical Engineering; Doctoral Supervisor and Postdoctoral Supervisor; Foreign Member of the Russian Academy of Engineering; Fellow of the European Academy of Translational Medicine; Fellow of the Royal Society of Medicine, UK. Recognized as Class-A Talent of Guangdong Province, Class-A Talent of Anhui Province, and Local Leading Talent.

Winner of the Second Prize of the National Science and Technology Progress Award (2017); Recipient of the Personality Award of the China Invention and Innovation Award (2023); Winner of the First Prize of the China Invention Award (2024); Winner of the First Prize of the Science and Technology Award of the China Council for the Promotion of Science and Technology Industrialization (2025). Selected as one of Elsevier’s Highly Cited Chinese Researchers for five consecutive years (2020–2024), and listed in the Stanford University Top 2% Scientists Worldwide Ranking.

Currently serving as Distinguished Professor at the Future Medical Center of Shenzhen University of Advanced Technology and Academic Leader of the Department of Nephrology at its Affiliated Hospital; Visiting Professor at Baylor Scott & White Health and Texas A&M University College of Medicine, USA. Concurrent Appointments: Chief Expert of the Key Discipline of Rheumatology and Immunology at Peking University Shenzhen Hospital; Chief Expert of the Institute of Inflammatory and Immune Diseases at Shenzhen Peking University–Hong Kong University of Science and Technology Medical Center; Chief Expert of the Department of Organ Transplantation at the 924th Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army; Professor and Deputy Director of the Institute of Nephrology and Blood Purification at Jinan University. Prof. Dai has previously held positions as Professor and Doctoral Supervisor at Jinan University, Southern University of Science and Technology, Chongqing Medical University, and Tongji Medical College of Huazhong University of Science and Technology.

Education and Professional Experience:

Education:

2002.06–2003.01, Department of Nephrology, Nuremberg General Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Postdoctoral Research Fellow & Senior Visiting Scholar

1987.10–1992.07, Sun Yat-sen University of Medical Sciences (Sun Yat-sen University), Ph.D. Internal Medicine (Nephrology)

1978.10–1983.08, Wuhan Medical College (Tongji Medical College, Huazhong University of Science and Technology), M.S. Medicine

Work Experience：

2025.11–Present, Distinguished Professor, Future Medical Center, Shenzhen University of Advanced Technology; Academic Leader of the Department of Nephrology, Affiliated Hospital

2023.02–2025.10, Chief Expert, Department of Rheumatology and Immunology (Key Discipline), Peking University Shenzhen Hospital; Chief Expert, Institute of Inflammatory and Immune Diseases, Shenzhen Peking University–Hong Kong University of Science and Technology Medical Center

2024.11–2025.12, (Concurrent Appointment) Distinguished Professor, Department of Nephrology, The Seventh Affiliated Hospital of Sun Yat-sen University

2023.02–2025.10, (Concurrent Appointment) Chief Scientist, Pingshan Center, Shenzhen Bay Laboratory (Key Project of Shenzhen Municipality)

2023.04–Present, (Concurrent Appointment) Chief Expert, Department of Organ Transplantation, The 924th Hospital, Joint Logistics Support Force of the Chinese People’s Liberation Army

2023.03–2024.09, (Concurrent Appointment) Director, Taizhou Health Industry Research Center, Southern University of Science and Technology; Director, Taizhou Key Laboratory for Autoimmune Disease Diagnostic Technology, Zhejiang Province; Expert, Dai Yong Expert Workstation for Provincial and Municipal Distinguished Experts, Taizhou City, Zhejiang Province; Member, Taizhou Science and Technology Innovation Advisory Committee;Founder and President, Zhejiang Taizhou Liyan Medical Technology Co., Ltd.

2018.06–2022.10, Chief Physician and Doctoral Supervisor, Department of Nephrology, The Second Clinical Medical College of Jinan University & The First Affiliated Hospital of Southern University of Science and Technology; Director, Clinical Medical Research Center; Deputy Director, Institute of Nephrology and Blood Purification, Jinan University. (Concurrent Appointments: 2018.12–2022.10, Director, Guangdong Provincial Engineering Research Center for Precision Medicine of Autoimmune Diseases; 2020.10–2022.10, Director, Shenzhen Engineering Research Center for Autoimmune Diseases)

2017.02–Present, Visiting Professor, Baylor Scott & White Health and Texas A&M University College of Medicine, USA

2008.08–2018.06, Director, Clinical Medical Research Center, The Second Clinical Medical College of Jinan University & The First Affiliated Hospital of Southern University of Science and Technology. (Concurrent Appointments: 2006.09–2018.09, Deputy Director, PLA Nephrology Transplantation and Dialysis Treatment Center & Deputy Director of Institute of Nephrology, Guangzhou Military Region, Guilin Hospital Affiliated to Southern Medical University;  2010.11–2020.12, Deputy Director, Guangxi Key Laboratory of Metabolic Diseases; 2017.04–2022.10, Director, Guangdong Provincial Clinical Medical Research Center for Birth Defects)

1998.07–2006.08, Director, Clinical Medical Research Center and Deputy Director, Department of Nephrology, The Second Clinical Medical College of Jinan University & The First Affiliated Hospital of Southern University of Science and Technology. (Professional Title: Certified as Chief Physician in Dec 2000; Concurrent Appointments: 2002.08–2006.08, Deputy Director and Director of Basic Research Division, Shenzhen Institute of Geriatrics; 2002.05–2003.01, Postdoctoral Research Fellow and Visiting Scholar, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany)

2006.08–2008.08, Director, Department of Blood Purification, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital).(Professional Title: Promoted to Professor in Aug 2006; Concurrent Appointment: 2007.08–2022.10, Director, Shenzhen Public Technology Platform for Stem Cell and Cell Transplantation)

2003.05–2006.05, (Concurrent Appointment) Adjunct Professor and Doctoral Supervisor, Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Adjunct Professor and Doctoral Supervisor, Department of Medical Laboratory Science (National Key Discipline), Chongqing Medical University

1997.07–1998.07, Deputy Director, Central Laboratory, Shenzhen People’s Hospital (The Second Affiliated Hospital of Jinan University School of Medicine)

1994.10–1997.07, Associate Chief Physician, Department of Nephrology, Shenzhen People’s Hospital

1992.07–1994.10, Attending Physician, Department of Nephrology, Shenzhen People’s Hospital.(Concurrent Appointments: 1993.10–1997.08, Lecturer in Internal Medicine, Guangzhou Medical University and Jinan University School of Medicine; Promoted to Lecturer in Oct 1993; Promoted to Associate Professor in Oct 1994)

Academic Achievements:

International Academic Influence:

Prof. Dai has been selected as one of Elsevier Highly Cited Chinese Researchers for five consecutive years from 2020 to 2024, listed among the world’s top scientists for three consecutive years, and included in the Stanford University Top 2% Scientists Worldwide Ranking. He ranks among the top 1.36% of global scholars in the Scholar GPS database. Prof. Dai was recognized as one of the Top 10 Most Active Nephrology Scholars in China in 2021 and one of the Top 5 in 2022. He served as Chairman of the 20th World Congress of Nephrologists held in London, UK, in 2019. Over the past five years, he has chaired 5 major domestic and international academic conferences and delivered keynote speeches at 16 academic events. He also serves as an editorial board member of multiple international academic journals.

Honors and Awards:

Prof. Dai has obtained a total of 34 scientific research achievement awards at all levels. Among them are 20 provincial and ministerial-level accolades, including the Second Prize of the National Science and Technology Progress Award (2017), the Personage Award of the China Invention and Innovation Award (2023), the First Prize of the China Invention Award (2024), and the First Prize of the Science and Technology Award issued by the China Council for the Promotion of Science and Technology Industrialization (2025). He has been awarded 20 honors as the first completer of research projects.

Research Achievements:

As the principal investigator, Prof. Dai has undertaken and completed 30 research projects at all levels, including programs supported by the National Natural Science Foundation of China. He has published a total of 956 academic papers in domestic and international journals, among which 352 are indexed by the Science Citation Index (SCI), and 250 SCI papers have been published as the first author or corresponding author.

Prof. Dai has authored or participated in compiling 11 academic monographs, including 5 overseas publications. He has been granted 37 authorized invention patents. He was ranked among the Top 20 (9th nationally) in the number of authorized invention patents in the field of nephrology across China in 2022, and won the First Prize in the AI + Energy Security Special Competition of the 2025 National General Artificial Intelligence Innovation and Application Competition. Prof. Dai has secured over 20 million RMB in funds for research achievement transformation. A number of his research outcomes have been applied in clinical practice and successfully industrialized.